Immunotherapy for childhood aplastic anemia in India: a case for universal healthcare?


Aplastic anemia in childhood is a difficult condition to treat, and Nair and colleagues are to be commended for their meticulous collection of single-center data over a 22year period [1]. They evaluated the efficacy of immunosuppressive therapy (IST) with antithymocyte globulin (ATG) and cyclosporine (CSA) on 33 pediatric patients with acquired aplastic… (More)